Retinal physiology in metabolic syndrome

Area of Science:

• Ophthalmology
• Endocrinology
• Metabolic Syndrome

Background:

• Obesity presents systemic health risks and is increasingly linked to visual defects and eye diseases.
• Metabolic dysregulation in obesity compromises ocular tissues, including the retina and optic nerve.
• Key risk factors exacerbated by obesity include hypertension, dyslipidemia, and insulin resistance.

Purpose of the Study:

• To explore the intricate relationship between obesity and ocular health.
• To elucidate the mechanisms by which metabolic dysregulation influences visual outcomes.
• To highlight preventive and therapeutic strategies for vision loss in obese individuals.

Main Methods:

• Review of current literature on obesity, metabolic syndrome, and eye diseases.
• Discussion of pathogenic pathways linking metabolic factors to retinal and optic nerve damage.
• Examination of inflammation, oxidative stress, and vascular dysfunction in obesity-related eye conditions.

Main Results:

• Obesity exacerbates conditions such as diabetic retinopathy, age-related macular degeneration, and glaucoma.
• Adipose-derived cytokines and insulin resistance disrupt retinal homeostasis and vasculature.
• Emerging evidence points to genetic factors influencing diabetic retinopathy in the context of obesity.

Conclusions:

• Metabolic dysregulation in obesity is a significant driver of ocular pathology and vision impairment.
• Targeting metabolic pathways and inflammation may offer therapeutic benefits for eye diseases in obese patients.
• Further research into genetic factors can enhance understanding and treatment of obesity-related vision loss.